BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17461503)

  • 1. Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinoma.
    Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
    World J Gastroenterol; 2007 Apr; 13(13):1989-94. PubMed ID: 17461503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells' growth in vitro and in vivo.
    Yang Y; Lv QJ; Du QY; Yang BH; Lin RX; Wang SQ
    World J Gastroenterol; 2005 Apr; 11(16):2491-6. PubMed ID: 15832424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells.
    Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
    Acta Pharmacol Sin; 2006 Dec; 27(12):1630-6. PubMed ID: 17112419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergism of an antisense oligodeoxynucleotides targeted to hTERT in combination with chemotherapeutic drugs on inhibiting the proliferation of HepG2 cells].
    Yang Y; Du QY; Wang SQ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):719-21. PubMed ID: 14697130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles.
    Dai LC; Yao X; Wang X; Niu SQ; Zhou LF; Fu FF; Yang SX; Ping JL
    World J Gastroenterol; 2009 Apr; 15(16):1966-72. PubMed ID: 19399928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model.
    Dai LC; Wang X; Yao X; Min LS; Ping JL; He JF
    Acta Pharmacol Sin; 2007 Mar; 28(3):453-8. PubMed ID: 17303011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis.
    Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
    World J Gastroenterol; 2007 Feb; 13(8):1208-13. PubMed ID: 17451201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma.
    Hu XY; Liang JY; Guo XJ; Liu L; Guo YB
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large scale preparation of midkine antisense oligonucleotides nanoliposomes by a cross-flow injection technique combined with ultrafiltration and high-pressure extrusion procedures.
    Zhong J; Yao X; Li DL; Li LQ; Zhou LF; Huang HL; Min LS; Li J; Fu FF; Dai LC
    Int J Pharm; 2013 Jan; 441(1-2):712-20. PubMed ID: 23142083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.
    Wang Z; Gu C; Wang X; Lang Y; Wu Y; Wu X; Zhu X; Wang K; Yang H
    Med Oncol; 2019 Oct; 36(12):97. PubMed ID: 31664534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
    Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X
    Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
    Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
    Xiong YQ; Sun HC; Zhu XD; Zhang W; Zhuang PY; Zhang JB; Xu HX; Kong LQ; Wu WZ; Qin LX; Tang ZY
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):505-12. PubMed ID: 20490863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
    Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
    Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro chemosensitivity of hepatocellular carcinoma for hepatic arterial infusion chemotherapy using the MTT assay with the combinations of antitumor drugs.
    Furukawa S
    Kurume Med J; 2004; 51(1):25-33. PubMed ID: 15150897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma.
    Kang HG; Wang BZ; Zhang J; Liu MR; Li YX
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):197-203. PubMed ID: 27863926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
    Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
    Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma.
    He X; Li J; Guo W; Liu W; Yu J; Song W; Dong L; Wang F; Yu S; Zheng Y; Chen S; Kong Y; Liu C
    Oncotarget; 2015 Feb; 6(4):2302-14. PubMed ID: 25544773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.